Buyer Beware: THC Breathalyzer Won’t Save Cannabix’s Stock Posted by Matthew Clark | Feb 5, 2021 | Investing Cannabix Technologies’ THC breathalyzer could be a huge success if cannabis is legalized in the U.S., but Cannabix’s stock still isn’t a buy. Read More
Fulgent (FLGT): Go Beyond 23andMe With This Surging Genetics Stock Posted by Matthew Clark | Feb 4, 2021 | Investing, Podcast In this episode of The Bull & The Bear podcast, I highlight Fulgent Genetics Inc. (Nasdaq:... Read More
The $560B EV Boom Is Coming — Profit With 1 Alternative Stock Posted by Matthew Clark | Feb 3, 2021 | Investing Magna International Inc.’s (NYSE: MGA) stock is a buy at it supplies key components to some of the largest electric vehicle manufacturers. Read More
Broadcom: This 5G Dividend’s $27B Sales Projection Is Stock Jet Fuel Posted by Matthew Clark | Feb 2, 2021 | Investing Broadcom Inc. (Nasdaq: AVGO) is a key player within 5G, and its future sales should send this 5G dividend stock’s price even higher. Read More
Vaccine Boom Over? Watch Pfizer’s Earnings to Find Out Posted by Matthew Clark | Jan 31, 2021 | Markets Money & Markets Week Ahead for February 1, 2021: Pfizer’s earnings should tell us how profitable COVID-19 vaccine efforts have been. Read More